Carregant...
The role of erenumab in the treatment of migraine
Calcitonin gene related peptide (CGRP) monoclonal antibodies (mAbs) have been the first class of specifically developed preventive treatments for migraine. Clinical trials data suggest superiority of the CGRP mAbs to placebo in terms of prevention of migraine symptoms, migraine-specific quality of l...
Guardat en:
| Publicat a: | Ther Adv Neurol Disord |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
SAGE Publications
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7257830/ https://ncbi.nlm.nih.gov/pubmed/32523630 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756286420927119 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|